Synageva Biopharma (GEVA) more than doubles as Alexion buys

May 6, 2015 10:56 AM | 11 seconds read |
Synageva Biopharma Corp GEVA shares surged 116% to $207.06 after Alexion Pharmaceuticals, Inc. announced its plans to acquire Synageva for $8.4 billion. Share volume was 7.7 million, dwarfing an all-day average of 317,000
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!